2 outstanding ASX 200 shares to buy this month according to analysts

Here are a couple of ASX 200 shares that have been rated as buys…

| More on:
a man in a business suite throws his arms open wide above his head and raises his face with his mouth open in celebration in front of a background of an illuminated board tracking stock market movements.

Image source: Getty Images

There are a lot of options for investors to choose from on the ASX 200. Two that could be in the buy zone right now are listed below.

Here’s why analysts rate them as buys:

Aristocrat Leisure Limited (ASX: ALL)

The first ASX 200 share to look at is Aristocrat Leisure. It is one of the world’s leading gaming technology companies responsible for many of the most popular pokie machines globally. In addition to this, the company has a growing digital business with a portfolio of hugely popular mobile games such as RAID: Shadow Legends. It is also in the process of acquiring UK listed real money gaming business Playtech for $3.9 billion.

Morgans is a fan of the company and currently has an add rating and $52.00 price target on its shares.

It commented: “We reiterate our ADD rating. In our opinion, the acquisition of PTEC gives ALL the opportunity to get to scale quickly in a market segment forecast to grow at a double-digit rate over the next five years. We expect the strong sector growth to be driven by a North America market growing at a CAGR of close to 50% as more US states liberalise and allow online iGaming and online sports betting.”

CSL Limited (ASX: CSL)

Another ASX 200 share that could be in the buy zone is CSL. It is one of the world’s leading biotechnology companies, comprising the CSL Behring and Seqirus businesses. Both are leaders in their respective fields – plasma therapies and vaccines.

Citi is bullish on the company, particularly following its Vifor Pharma acquisition announcement, and appears to see the weakness in the CSL share price as a buying opportunity for investors. It has a buy rating and $340.00 price target on its shares.

Citi said: “CSL has announced that the acquisition of Vifor Pharma – it is acquiring the company at CHF165.5 (US$179.25), a ~65% premium to where the stock was trading pre bid discussion and a ~37% premium to the three-month VWAP. We calculate the acquisition to be ~9% accretive to NPATA per share (NPAT before acquisition-related amortization) – a proxy for cash flow.”

Wondering where you should invest $1,000 right now?

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes could be the five best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.

*Returns as of January 12th 2022

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns and has recommended CSL Ltd. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Blue Chip Shares

Red buy button on an apple keyboard with a finger on it.
Blue Chip Shares

Brokers name 2 ASX 200 blue chip shares to buy

These blue chip shares are rated highly by analysts...

Read more »

Woman with money on the table and looking upwards.
Dividend Investing

2 ASX dividend shares I’d buy with $1,000

Brickworks and Wesfarmers are two of the leading ASX dividend shares I’d consider.

Read more »

A man with a yellow background makes an annoncement, indicating share price changes on the ASX
Broker Notes

Broker names 3 more ‘champion’ ASX 200 shares to buy and hold

Here are three more "champion stocks" for buy and hold investors...

Read more »

a woman holds a facebook like thumbs up sign high above her head. She has a very happy smile on her face.
Blue Chip Shares

Broker names 2 of the ‘best’ blue chip ASX 200 shares to buy now

These ASX 200 shares are rated highly by a leading broker...

Read more »

Three people in a corporate office pour over a tablet, ready to invest.
Blue Chip Shares

2 strong blue chip ASX 200 shares to buy after the market selloff according to analysts

These blue chip shares could be buys...

Read more »

three businessmen high five each other outside an office building with graphic images of graphs and metrics superimposed on the shot.
Blue Chip Shares

2 ASX 200 shares that analysts say are buys

Here are two ASX 200 shares to buy...

Read more »

shares record high
Broker Notes

Broker names 3 ‘champion’ ASX 200 shares to buy and hold

Here are three "champion stocks" for buy and hold investors...

Read more »

Three people in a corporate office pour over a tablet, ready to invest.
Blue Chip Shares

2 highly rated blue chip ASX 200 shares brokers rate as buys

Here are a couple of blue chip shares that have been rated as buys...

Read more »